Johnson & Johnson to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference

Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 44th Annual Global Healthcare Conference on Tuesday, June 13th, at the Waldorf Astoria Monarch Beach Resort & Club in Dana Point, CA. Biljana Naumovic, Worldwide Vice President, Oncology, and Peter Lebowitz, Global Therapeutic Head, Oncology, will represent the Company in a session scheduled at 4:20 p.m. (Eastern Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast replay will be available approximately 48-hrs after the live webcast.

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  228.82
+7.55 (3.41%)
AAPL  272.51
+0.67 (0.25%)
AMD  203.25
+5.14 (2.59%)
BAC  54.65
+0.10 (0.17%)
GOOG  303.80
+5.74 (1.93%)
META  668.29
+18.79 (2.89%)
MSFT  487.98
+11.86 (2.49%)
NVDA  175.35
+4.41 (2.58%)
ORCL  181.60
+3.14 (1.76%)
TSLA  489.94
+22.69 (4.85%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.